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Abstract
Antimicrobial peptides (AMPs), produced by a wide range of organisms, have attracted attention due to their potential use
as novel antibiotics. The majority of these peptides are cationic and are thought to function by permeabilizing the bacterial
membrane, either by making pores or by dissolving it (‘carpet’ model). A key hypothesis in the literature is that antimicrobial
and hemolytic activity correlate with binding affinity to anionic and zwitterionic membranes, respectively. Here we test this
hypothesis by using binding free energy data collected from the literature and theoretical binding energies calculated from
implicit membrane models for 53 helical AMPs. We indeed find a correlation between binding energy and biological activity,
depending on membrane anionic content: antibacterial activity correlates best with transfer energy to membranes with
anionic lipid fraction higher than 30% and hemolytic activity correlates best with transfer energy to a 10% anionic
membrane. However, the correlations are weak, with correlation coefficient up to 0.4. Weak correlations of the biological
activities have also been found with other physical descriptors of the peptides, such as surface area occupation, which
correlates significantly with antibacterial activity; insertion depth, which correlates significantly with hemolytic activity; and
structural fluctuation, which correlates significantly with both activities. The membrane surface coverage by many peptides
at the MIC is estimated to be much lower than would be required for the ‘carpet’ mechanism. Those peptides that are active
at low surface coverage tend to be those identified in the literature as pore-forming. The transfer energy from planar
membrane to cylindrical and toroidal pores was also calculated for these peptides. The transfer energy to toroidal pores is
negative in almost all cases while that to cylindrical pores is more favorable in neutral than in anionic membranes. The
transfer energy to pores correlates with the deviation from predictions of the ‘carpet’ model.
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Introduction
Antimicrobial peptides (AMPs) are found in a wide variety of
organisms such as plants, insects, and vertebrates, providing a
host-defense mechanism against invading microbial species [1–4].
These peptides usually exhibit selectivity against prokaryotic
pathogen cells over the host cells [5–7]. Some show selectivity
for fungi, cancer cells and parasites [8,9]. AMPs are thought to be
less likely to elicit resistance than traditional antibiotics, and this
gives them potential for clinical applications [10]. Some AMPs
have been found to have intracellular targets, but the majority are
thought to kill bacteria by disrupting the cell membrane [11–14]
either by pore formation [15] or by detergent-like disintegration
(the ‘carpet’ model)[16]. Even when AMPs target intracellular
sites, they still have to cross the cell membrane. Experiments with
several AMPs have shown their ability to translocate across cell
and liposome membranes, a property they share with cell-
penetrating peptides[17]. Thus, understanding the process of
translocation and pore formation could have wide-ranging
implications.
Despite the vast amount of biological and biophysical data
collected on AMPs, unifying concepts are still lacking. It is not yet
possible to look at the sequence and even the structure and
thermodynamic properties of a peptide and predict whether it is
antimicrobial or cell-penetrating. Some peptides are helical, others
contain beta structures, and still others are unstructured. Even
random copolymers that lack a regular folding pattern have been
shown to possess antimicrobial activity[18]. Thus, secondary
structure does not provide any guidance. Several bioinformatics
methods have been proposed to identify and predict the activity of
AMPs based on simple descriptors like hydrophobicity, amphi-
pathicity, charge, or helicity [19–21]. They are partially successful
[7,22–27] but the lack of connection to a physical mechanism
places limits in their applicability and ultimate utility.
An intuitive idea is that the biological activity of a peptide
should be related to its affinity for the target membrane. Most, but
not all, AMPs are cationic, and this provides an intuitive
rationalization for their targeting bacteria: bacterial membranes
are negatively charged, whereas the outer leaflet of eukaryotic
membrane is neutral [7,28,29]. This hypothesis is supported by a
lot of anecdotal evidence and has been stated most explicitly in
recent work [30,31]. If the ‘carpet’ model were universally valid,
one would expect a perfect correlation of biological activity with
membrane binding affinity. However, this correlation might break
down in practice due to presence of other steps, such as membrane
insertion and pore formation. For instance, the cationic melittin
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exhibits higher affinity for negatively charged membranes but its
permeabilizing activity is higher for zwitterionic vesicles [32,33]. A
peptide could, in principle, bind very strongly (especially if inserted
perpendicularly to the membrane surface) without causing any
damage to the membrane or compromising its barrier proper-
ties[34]. Another reason for lack of correlation with membrane
binding affinity could be the complexity of the biological process:
for example, to get to the plasma membrane AMPs need to
traverse either the outer membrane of gram negative bacteria or
the cell wall of gram positive bacteria [35]. The activity of a
peptide could be affected by these steps (if they are rate-limiting)
rather than the interaction with the plasma membrane.
Recent work in our group showed that the hemolytic activity of
a series of four peptides correlated with a theoretical estimate of
the binding affinity to a zwitterionic bilayer [36]. The correlation
was observed whether one used the binding energy to the planar
bilayer, the binding energy to the pore, or the difference between
the two. The goal of the present work is to perform a systematic,
larger-scale test of this hypothesis. First we examine the correlation
between experimental affinity and biological activity data across a
wide variety of helical AMPs. Then we complement these data
with computational studies using an implicit membrane model
which can account for the effect of membrane surface charge[37].
Computational studies have the advantage that they are
performed under the same conditions and provide structural
information, within the uncertainties, of course, of the theoretical
treatment. A set of 53 helical peptides that have known biological
activities and 3D structures were considered and their interfacial
binding energy to zwitterionic and anionic membranes was
calculated by molecular dynamics (MD) simulations.
There are several challenges in the compilation of experimental
data. One difficulty is that the reported binding free energies are
not always comparable. Most studies analyze the data using the
‘‘single set of sites’’ model, i.e. treating the membrane as a receptor
with many, equivalent, and independent binding sites. Others use
a simple mass action law[30] while others use a partitioning
formalism[38,39]. The Seelig group reports free energies that have
been corrected for generic electrostatic effects using the Gouy-
Chapman theory[40]. To be comparable, data have to be
converted to the same standard state (see Section S1). Biological
activity data present even more severe challenges. The calculated
MIC values are sensitive to a variety of conditions: the bacterial
strain, the culture medium[41], the salt concentration[42], the
bacterial concentration[43], etc. As a result, MIC values for the
same peptide and for the same bacterium reported by different
laboratories are often very different. For example, the MIC of
magainin against E. Coli has been reported as 0.4,2.8 mM[42] or
38 mM[44]. These uncertainties will introduce significant scatter in
any attempt to correlate data on a large scale. However, some
signal should still be visible.
We found that the surface charge difference between bacterial
and eukaryotic membranes is indeed an important determinant of
peptide selectivity: antibacterial activity correlates best with
transfer energy to a membrane containing over 30% anionic
lipid; hemolytic activity correlates best with transfer energy to a
membrane containing 10% anionic lipid. Other physical descrip-
tors, in addition to membrane binding energy, were also found to
correlate with biological activity: surface area occupation of the
peptide is an important descriptor for antibacterial activity;
insertion depth is an important factor in hemolytic activity, while
structural flexibility affects both antibacterial activity and hemo-
lytic activity. The membrane surface coverage by many peptides at
the MIC is estimated to be much lower than would be required by
a ‘carpet’ mechanism. The peptides suggested in the literature to
form pores are highly likely to have lower surface coverage than
those suggested to act by the ‘carpet’ model. Using implicit
membrane modeling, we were also able to calculate the transfer
energy to pores. Formation of a toroidal pore is more likely than
barrel-stave pore for most peptides. The deviation from predic-
tions of the ‘carpet’ model was found to correlate with transfer
energy to pores.
Results and Discussion
a) Configurations of antimicrobial peptides at the
membrane interface
Antimicrobial peptides exhibit wide structural diversity. Even
after limiting the range to helical peptides, the peptide can be as
short as 13 residues (IsCT) or as long as 42 residues (moricin); it
can be highly helical (d-hemolysin) or mainly unfolded (SMAP29);
it can also be highly linear (mastoparan M) or have multiple
flexible hinges (moricin); the charge can range from -1
(alamethicin) to +12 (CAP18).
As a result, the behavior of the peptides at the membrane
interface is quite diverse. Figure 1 shows several lowest energy
conformations from the last 2ns of 4 ns of implicit membrane
simulations on 30% anionic membranes, using the protocol
described in the Materials and Methods section. The peptide can
insert deep into the hydrophobic core (8 Å, alamethicin) or only
penetrate shallowly (1 Å, such as fowlicidin-2); the tilt angle of the
peptide can range from 80u (pardaxin) to 120u (such as fowlicidin-
1). The structure can be quite rigid (rmsf , 0.9 Å, such as
mastoparan M) or can exhibit large fluctuations (rmsf . 5 Å, such
as moricin). The conformations on neutral membranes are similar,
except the binding energy is less negative and the peptide inserts
less deeply into the membrane.
b) Correlation between theoretical transfer energy and
experimental binding free energy
Thermodynamic data for membrane binding in the literature
are reported in a variety of standard states. For comparison
between them they need to be converted to the same standard
state. Section S1 in the supplementary material describes how this
is done and presents a compilation of data on AMPs.
The membrane binding free energy can be broken up into the
following contributions (see Section S1): a) the change in average
effective energy, D,W., which includes intramolecular and
solvation free energy changes, b) translational and rotational
entropy changes, c) the free energy of folding, if the soluble form is
disordered and the membrane-bound form has secondary
structure, and d) the disaggregation free energy, if the peptide is
aggregated in solution [45]. Using an implicit model it is relatively
straightforward to obtain D,W.: for each peptide, we place it on
the membrane or in water and calculate the difference in average
effective energy in MD simulations. However, for peptides that are
unfolded or aggregated in solution this simple approach is not
sufficient.
For peptides that are disordered in solution and fold into a helix
upon membrane binding, a useful approach might be to calculate
the free energy of the transition from membrane-bound helix to a
helix in solution. This value should be added to the free energy of
helix unfolding in solution, which for these peptides should be a
small number, not more than 2–3 kcal/mol [37]. The transla-
tional-rotational entropy of peptide adsorption to a membrane has
been estimated as 1.3 kcal/mol [46] and is likely to be similar for
different peptides. The effective energy of membrane binding of
the helix is estimated from the average transfer energy, ,DW.,
obtained by averaging the difference in effective energy between
Activity Determinants of Helical AMPs
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Figure 1. Typical conformations of antimicrobial peptides on anionic membranes. The lowest energy conformations in the last 2ns of 4 ns
implicit simulations on 30% anionic membranes are shown. The grey areas indicate the hydrophobic core of the membrane. The dotted lines indicate
the location of the phosphate groups. The colors on the peptides indicate the residue type: Red: acidic; Blue: basic; white: polar; green: uncharged
polar. Moricin (*): an alternative conformation of moricin (1kv4) with the same total energy.
doi:10.1371/journal.pone.0066440.g001
Table 1. Comparison of the experimental binding free energy with D,W. and ,DW..
Peptide PDBid Lipids DGc
0 ,DW. D,W. Ref.
Alamethicin 1amt DOPC –5.77 –8.660.2 –8.260.4 [89]
Mastoparan X 2czp POPC –4.7 –4.260.8 –4.060.6 [17]
d-hemolysin 2kam POPC –6.0 –12.660.5 –17.667.7 [30]
CM-15 2jmy DMPC –4.72 –8.360.9 –5.161.8 [90]
DMPG –5.49 –15.560.3 –14.163.2
Dermadistinctin K 2k9b egg PC –3.97 –3.161.7 –2.563.1 [91]
LL-37 2k6o SOPC –6.16 –12.760.4 –1.863.8 [92]
SOPC/POPG(7:3) –8.79* –19.161.9 –6.963.6
Magainin 2mag POPC –3.7 –5.460.6 –1.863.1 [93]
POPC:POPG(3:1) –5.98 –10.761.0 –7.662.8
Melittin 2mlt DOPC –5.1 –13.160.7 –5.461.2 [94]
POPC/POPG(8:2) –8.2 –18.662.5 –17.064.1 [95]
Pardaxin 1xc0 POPC –6.21 –22.160.8 –7.062.3 [96]
*Interpolated from other anionic fractions.
doi:10.1371/journal.pone.0066440.t001
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membrane and aqueous phase for every conformation generated
during the membrane simulation. ,DW. has the added
advantage of a lower statistical uncertainty than D,W..
According to this rationale, ,DW. should be systematically
more negative than the experimental binding free energy by a few
kcal/mol.
We pursued both approaches and computed ,DW. from 4-ns
simulations on the membrane and D,W. from separate 100-ns
simulations both on the membrane and in solution. The results are
listed and compared with the experimental binding free energies in
Table 1. ,DW. is more negative than the DG in all cases except
for Dermadistinctin K and mastoparan X. The values of D,W.
are almost always smaller in magnitude than ,DW. and in most
cases closer to the values of DG. In the long simulations used to
compute D,W., we observed that most peptides maintained
their initial structure on the membrane but became partially or
completely unfolded in water. Only Dermadistinctin K and
mastoparan X stayed mainly helical in water. This may indicate
that, although these peptides are unstructured in solution [47,48],
the free energy of helix unfolding we neglected in ,DW. may be
smaller in these two cases than for the other peptides.
Scatter plots that compare DG with , DW. and D,W. are
shown in figure 2. A strong linear relationship can be found
between ,DW. and DGexp:
DGexp~0:196+0:045 vDWw{3:43+0:60, R2~0:62 (1)
The correlation between DG and D,W. is much weaker (Fig.
2b). Extending some of the simulations up to 1000 ns did not
improve the results significantly. Excluding the points that clearly
do not fit (CM-15(*), Melittin(*), pardaxin), a linear relationship
between D,W. and DGexp can also be established but with
higher uncertainty:
DGexp~0:341+0:176 vDWw{3:80+0:97, R2~0:32 (2)
All-atom explicit simulations also exhibit significant deviations
from experimental binding free energies. Several cases are listed in
Table S4 and compared to transfer energies using the present
implicit model. In some cases, the binding free energies calculated
from explicit simulations are comparable to ,DW.. In other
cases, the ,DW. from implicit simulations is closer to the
experimental value than the explicit simulation result. As
explained above, an important missing factor in these calculations
is conformational entropy. For b antimicrobial peptides which
have relative rigid structure, the transfer energy ,DW. is closer
to the binding free energy.
Even though not directly comparable with experimental
binding free energy, ,DW. can still be quite useful in practice
thanks to its linear relationship with DGexp. In addition,
calculating ,DW. requires much less computing effort.
c) Correlation between experimental membrane binding
free energy and biological activity
To examine the relationship between membrane partition and
biological activity, we collected from the literature minimal
inhibitory concentrations (MIC) for antibacterial activity and
50% hemolysis concentrations (EC50) for hemolytic activity.
Tables S2 and S3 list the collected data. Table S1 lists
experimental binding free energies from the literature. Because
concentrations are exponentially related to energies (see Eq. 14),
we plot the natural log of MIC and EC50 against the binding
energy to neutral or anionic membranes in Figure 3. There is
considerable scatter in the data, but some correlations are visible.
The linear correlation coefficient (R) between the ln(MIC) and
binding energy to anionic membrane is 0.46 and 0.62 for anionic
lipid fraction 25–30% and 50% respectively. The correlation for
100% anionic membrane, however, is negative largely due to a
single data point: CM-15 is quite effective even though its
membrane binding was measured to be rather weak. The binding
energy to neutral membrane has a weak negative correlation
(R = –0.32) with the ln(MIC).
The linear correlation coefficient between the ln(EC50) and
neutral membrane affinity is 0.60. Similar correlation is observed
between ln(EC50) and anionic membrane affinity (R = 0.57 and
0.91 for anionic lipid fraction 25–30% and 50% respectively).
d) Correlation between theoretical transfer energy and
biological activity
For many peptides, the experimental binding free energy is not
available, especially to anionic lipids. These are obtained here
theoretically using an implicit membrane model. We ran MD
simulations at different anionic fractions (anfr) and calculated the
correlation coefficient (R) between ,DW. and natural log of
biological effective concentrations (figure 4a). Antibacterial activity
against all three organisms correlates best with transfer energy to
$ 30% anionic lipid membrane and quickly diminishes as the
anionic fraction approaches 0%. The correlation to hemolytic
Figure 2. Correlation between theoretical binding energy and
experimental binding energy DGexp. Binding energy values that
are measured in anionic membranes are marked with (*). Upper panel,
, D W.. Lower panel, D , W..
doi:10.1371/journal.pone.0066440.g002
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activity is largely independent of anionic fraction; it is actually
somewhat larger for 10% anionic fraction. It is difficult to say
whether this slight increase in correlation is significant. It is worth
noting, however, that the erythrocyte membrane contains around
30% phosphatidylserine (PS) in the inner leaflet[49]. Considering
that the antimicrobial peptides can form pores, translocate
through the membrane or induce lipid flip-flop in the membrane,
it is conceivable that they could interact with the anionic lipids in
the inner leaflet. In addition, the outer leaflet of erythrocyte
membrane contains glycoproteins and glycolipids possessing
anionic sialic acid groups [50,51]. Specific scatter plots of the
data are shown in figure 4 b&c. The linear correlation is slightly
Figure 3. Correlation between experimental binding energy and biological activity. The lines are the best fit lines. a) DGanionic in 25–100%
anionic lipid and antibacterial activity against E. Coli. b) DGneutral and hemolytic activity. c) DGneutral and antibacterial activity. d) DGanionic and
hemolytic activity. The data points are chosen from Table S1. The unit of MIC and EC50 is mM.
doi:10.1371/journal.pone.0066440.g003
Figure 4. Correlation between transfer energy and biological effective concentrations. a) The effect of anionic lipid fraction (Anfr) on the
correlation coefficient(S) between transfer energy ,DW. and biological effective concentrations. b) ln(MIC) against E. Coli c). ln(EC50) against red
blood cells. The ,DW. and effective concentration values shown here are listed in Table S2.The unit of MIC and EC50 is mM. Red lines in b) and c) are
the best fit lines.
doi:10.1371/journal.pone.0066440.g004
Activity Determinants of Helical AMPs
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lower, due to the increased sample size and the difference between
,DW. and DG, but still is statistically significant.
These data, together with those of the previous section lead to
similar conclusions: a) there is a statistically significant correlation
between binding energies and biological activities, b) electrostatic
interactions are important for antimicrobial activity but much less
so for hemolytic activity, and c) the scatter in the plots shows that
membrane affinity is likely not the sole determinant of activity.
e) Test of the ‘carpet’ model
The ‘carpet’ model of AMP action proposes that peptides
accumulate on the membrane surface until a critical point is
reached at which the membrane disintegrates[16]. It has received
considerable support from solid state NMR experiments [52]. It is
possible, however, that these experiments detect a major, surface-
bound fraction rather than a minor fraction that forms pores [53].
In this simple model, AMP activity depends on only two
parameters: the membrane affinity of the peptide and the critical
surface coverage that a certain type of membrane can withstand.
The latter is not known, but it is reasonable to assume that it will
fall in the range 50–90%. In Methods we derive a simple equation
relating the MIC or the EC50 to these two parameters. If we insert
Eq. 1 into Eq. 15 and Eq. 16, we obtain:
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where the last term is a conversion factor frommM to M. Figure
5a plots the calculated ,DW. against ln(MIC*As) and eq.3 with
AL = 65 Å and vL = 0.76 M
21 [31] and different values of f*. The
f* = 0.9 line is close to the upper points in the plot, corresponding
to peptides that are rather inactive compared to their computed
binding affinity. A large number of points fall below the f* = 0.5
line, i.e. they are more active than the ‘carpet’ model predicts.
This can be an indication that these peptides act by a more
efficient mechanism, for example pore formation. Figure 5b plots








, we only plot the case of f* = 0.2. For
many peptides large values of f* are simply not feasible under the
conditions of the hemolysis experiments.
It is interesting to compare the position of each peptide in these
graphs to experimental data suggesting their mechanism of action.
In table S5, we collected information on the mechanism of various
peptides suggested in the literature. It should be noted that most of
these proclamations are based on circumstantial evidence that may
be in conflict with another. For example, LL-37 was found to
orient mainly parallel to membrane surface by Polarized ATR-
FTIR spectroscopy[55] but partly perpendicular to the membrane
surface by oriented CD spectroscopy[56]. Another example is
pardaxin, which was originally referred to as a pore forming
peptide[57] but more recent experiments suggested that it could
adopt the ‘carpet’ mechanism in the presence of anionic lipids or
cholesterol [58–60]. Sometimes, the conflict is reconcilable:
magainin is suggested to act through the ‘carpet’ mechanism on
eukaryotic cell membranes but not on bacterial membranes[61].
However, the stable pore formed in anionic membranes is
preceded by formation of a large opening [62], similar to the
ones thought to occur in the ‘carpet’ mechanism. Also, many of
the suggestions are based on in vitro experiments that may not be
entirely relevant to in vivo activities.
Keeping these caveats in mind, we marked the data points on
figure 5 according to the proposed mechanism for each peptide.
The peptides proposed to act by the ‘carpet’ mechanism are
marked by green color and those proposed to be ‘pore forming’
are marked by red color. In general, the former peptides are less
active and lie above the f* = 0.5 line while most pore-forming
peptides lie below this line. A few outliers can be observed,
primarily gaegurin-4 (2g9l) and LL37 (2k6o). The mechanism of
LL-37 (2k6o) is controversial: it has been suggested to form
pores[56] but also to act as a ‘carpet’[55,63–65].
Figure 5. Biological activity of peptides plotted against theoretical transfer energy. a) activity against E. Coli. b) activity against red blood
cells. The lines correspond to the theoretical expectation from the ‘carpet’ model for different value of the critical surface fraction covered. The red
points are the peptides proposed to adopt the ‘pore forming’ mechanism. The green points are the peptides proposed to adopt the ‘carpet’
mechanism. The black points are the peptides that have unknown mechanism.
doi:10.1371/journal.pone.0066440.g005
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f) Correlation between transfer energy to pores and
deviation from the ‘carpet’ model
Pore formation is a complex process with many contributions:
peptide-lipid interaction, possibly peptide-peptide interaction, and
the lipid deformation energy. But since forming a lipidic pore is
energetically unfavorable[66], if a peptide tends to induce pore
formation, the transfer energy of a single peptide to lipidic pores
should be favorable. In previous work [36], four antimicrobial
peptides were found to bind more strongly to toroidal pores than
to the planar membrane. Here we extend this work to a larger
number of peptides and to anionic pores [67]. We calculated the
transfer energy of the peptides to pre-formed cylindrical and
toroidal pores in neutral, 10% anionic and 30% anionic
membrane of radius R0 = 13Å. The values are shown in Table
S6. We observed that all peptides have favorable transfer energy to
anionic toroidal pores. Transfer energy to cylindrical pores in
anionic membranes is only favorable for a few peptides. In neutral
membrane, the transfer energy to both pores is favorable for most
peptides. Pardaxin (1xc0) has unfavorable transfer energy to any
type of pore in neutral and 10% anionic membranes, even though
a pore formation mechanism was proposed for it[57]. The peptide
changed into a hairpin like structure in toroidal pores. It may be
that the peptide adopts a specific structure that we have not been
able to sample and that this is a metastable structure. Peptide-
peptide interactions, which we haven’t taken into account in this
study, may also contribute to stabilizing the pore [68].
If pore formation makes the peptide more effective than the
‘carpet’ model would predict, we should observe that the reduction




expected for the ‘carpet’ model is positively correlated with the
transfer energy to pores. Figure 6 shows that this indeed is the
case: the more negative the DDW, the more likely the ln(MIC*As)
or ln (EC50  As{AL
f ½L
1{f 
) to be lower than the values
predicted by the ‘carpet’ model using f* = 0.9 or f* = 0.2 (to make




can be observed if f* = 0.9 was used for hemolytic activity but with
much fewer data points). The correlation is significant (p-Value #
0.1) except between Dln(MIC*AS) and DDWtor. Interestingly, the
transfer energy to cylindrical pores is more highly correlated with
Dln(MIC*As) than the transfer energy to toroidal pores, even
though the latter is more favorable. This might be due to
simplifications in the analysis, for example, toroidal pores induced
by different peptides may have different curvature K0 and
inhomogeneity factor h, but we are assuming they are constant
in our simulations.
g) Correlation between other physical descriptors and
biological activity
Empirical correlations between peptide physicochemical prop-
erties and their antimicrobial activities have been investigated in
the past [19,21,24,69–71]. MD simulations offer additional
descriptors that go beyond peptide sequence and secondary
structure. The correlations between these descriptors and the
biological effective concentrations are shown in Table 2. The
Spearman correlation coefficient is used here because it is not
affected by the actual mathematical relationship between effective
concentration and descriptor. Because the MIC and EC50




predictions of the ‘carpet’ model. cyl: the pore is a cylindrical pore with R = 13Å. tor: the pore is a toroidal pore with R = 13Å, K = 15Å, h = 0.6. The
anionic fractions of the lipids are 10% and 30% respectively for ln(MIC*As) and ln (EC50  As{AL
f ½L
1{f 
). The red lines are the best fitted lines. For
ln (EC50  As{AL
f ½L
1{f 
), [L] is assumed to be 20 mM and f* is assumed to be 0.2.
doi:10.1371/journal.pone.0066440.g006
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increase when the activity of the peptide decreases, positive
correlation in table 2 means unfavorable effect on the activity.
Not surprisingly, the electrostatic interaction is crucial for
selectivity: ncharge correlates significantly with antibacterial activity
but not so well with hemolytic activity. Peptide size (nres) also
correlates positively with the biological activity as previosly
revealed[72]. As found by previous studies [24,69], amphipathicity
is an important factor determining the activity of the peptide, even
surpassing in importance the overall hydrophobicity[73]. Another
quantity can be determined is the hydrophobic quadrupole
moment, which can serve as measure of imperfect amphipathicity
[36]. We list the hydrophobic quadrupole moment in Table S7
and show several peptides with various hydrophobic quadrupole
moments in Figure S1. The peptides that have high hydrophobic
quadrupole moment have either a kinked structure or their
nonpolar surface twined around the helix wheel. A peptide with
such type of structure should have better contacts with curved
surfaces such as toroidal pores. In contrast, peptides with low
hydrophobic quadrupole moment have balanced polar and
nonpolar residues. Indeed, our study indicates that the hydropho-
bic quadrupole is also an important determinant of biological
activity.
MD simulation provides additional information that could help
us identify important new activity determinants. As described in
previous sections, the transfer energy DW correlates with both
antibacterial and hemolytic activity. We observed that antibacte-
rial activity and hemolytic activity are affected differently by
membrane insertion, tilt angle and As. The membrane insertion
(both insertion volume V and insertion depth, the latter showing
stronger correlation) positively correlates with the hemolytic
activity but not antibacterial activity, consistent with the result
for the tilt angle; the closer the tilt angle is to 90o, the less active the
peptide is against erythrocytes. The surface area occupation As is
positively correlated with antibacterial activity but not hemolytic
activity. It has been found that the angle subtended by polar
residues is important to both antimicrobial activity and hemolytic
activity[74]. Decreasing the angle will increase both the insertion
into the membrane and the membrane surface area occupation of
the peptide. The fact that the electric dipole of the peptide is
unfavorably correlated with hemolytic activity is also consistent
with this trend: increasing the peptide dipole increases interactions
with the head groups and enhances the binding to membrane
interface while at the same time reducing the insertion into
membrane hydrophobic core.
The effect of helicity and structural flexibility is sometimes
ambiguous in experiments. Increasing the number of proline
residues in a peptide significantly reduced its channel-forming
activity and thus both antimicrobial and hemolytic activities [75].
Table 2. Correlation between the biological effective concentrations and biophysical descriptors.
MIC EC50
E.Coli. Red Blood Cell
Npept = 44 Npept = 19
ncharge The net charge of the peptides. –0.46 (1.7E-03) –0.13 (5.9E-01)
nres Number of residues. –0.36 (1.3E-02) –0.23 (3.4E-01)
H Hydrophobicity. –0.09 (5.8E-01) –0.08 (7.4E-01)
mH Hydrophobic moment. –0.45 (2.4E-03) –0.56 (1.3E-02)
QH Hydrophobic quadrupole moment. –0.39 (8.2E-03) –0.45 (5.1E-02)
DW Transfer energy of peptide from water to membrane surface. 0.46 (1.7E-03) 0.30 (2.1E-01)
V The immersed volume of peptide in the hydrophobic core of the membrane. –0.15 (3.4E-01) –0.22 (3.6E-01)
Depth The penetration depth of peptide residue into the hydrophobic core. Calculated as the
distance between the deepest residue and the membrane surface.
–0.14 (3.7E-01) –0.48 (3.7E-02)
Tilt The angle between peptide helix axis and membrane normal. 0.05 (7.6E-01) 0.29 (2.2E-01)
As Area of peptide occupied on the membrane surface. –0.40 (7.6E-03) 0.12 (6.3E-01)
Delec The electric dipole possessed by the peptide. –0.25 (9.6E-02) 0.39 (0.9E-01)
Helix% The percentage of helical structure. 0.25 (9.8E-02) 0.05 (8.3E-01)
nhelix The number of helical residues. –0.13 (3.9E-01) –0.25 (3.0E-01)
,nhbond. The number of hydrogen bonds per residue that were formed inside the peptide. –0.02 (8.8E-01) –0.02 (9.2E-01)
nhbond The number of hydrogen bonds. –0.28 (6.5E-02) –0.08 (7.4E-01)
rmsf The maximum fluctuation of any residue in the simulation.* –0.42 (4.3E-03) –0.17 (4.9E-01)
The p values are given in the parenthesis (two tails T-test, probability that the actual correlation is below the given value). The descriptors were calculated from 30%
anionic membrane simulations and 100% neutral membrane simulations respectively for correlating with MIC and EC50.
*If the average maximum fluctuation is used, the correlation is slightly lower.
doi:10.1371/journal.pone.0066440.t002
Figure 7. The predicted biological activity compared with the
actual biological activity. a) the ln(MIC) calculated for E.Coli.
membrane. b) the ln(EC50) calculated for Erythrocyte membrane.
doi:10.1371/journal.pone.0066440.g007
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The increased flexibility and reduced helicity of D-amino acid
containing peptides normally abrogated their hemolytic activity
but did not diminish their antibacterial activity [76–79]. Recent
research however showed that proline-containing peptides have
higher antibacterial activity and lower hemolytic activity [80]. We
observed that the structural flexibility (reflected by the structural
fluctuation in the MD simulations) is positively correlated with
both antibacterial and hemolytic activities. This may be due to a
lower entropy cost upon membrane binding, and thus a lower
membrane binding free energy. Alternatively, flexibility might be
required at subsequent steps, such as pore formation. The number
of helical residues (nhelix) and hydrogen bonds (nhbond) are
positively correlated with the biological activities. However,
increasing the helical percentage has a negative effect on the
biological activities, possibly because structural flexibility is
reduced. The average number of hydrogen bonds per residue
(,nhbond.) also has no correlation with biological activity.
Hemolytic activity generally correlates more with helix formation
and antibacterial activity correlates more with structural flexibility.
Using the above data, we can also establish a relationship
between biological activity and biophysical factors using multiple
linear regression:
ln½MIC~12:63z0:01821  DW30%anionic{0:03737  AS
z3:919E{5  A2S{0:2741  depthz0:3614  sin (tilt)
{0:1310  rmsf {0:2430  nch arg e, R2~0:46
ð5Þ
ln½EC50~11:93z0:1574  DW10%anionic
z0:01342 Delec{0:1814  depth{1:223  rmsf
{0:08303  helix%{0:1410  nch arg e, R2~0:79
ð6Þ
In the above equation, adding or dropping a descriptor will
reduce the correlation. The minimal set of parameters one needs
to describe the biological activities is quite different for antibac-
terial activity and hemolytic activity. Predicted values using the
above equations are plotted against the actual values in Figure 7.
Compared to other QSAR studies, the correlation of predicted
ln(MIC) with actual values is rather low. The mean square error is
6 1.5. Considering that the protocol of MIC/EC50 measurement
allows a difference in concentration of 2 fold and the fact that our
data points belong to different peptide families, the observed error
is reasonable.
Conclusions
Using experimental data and theoretical calculations we tested
the hypothesis that antimicrobial and hemolytic activity correlate
with the binding energy to the corresponding membranes. We
found that such correlations do indeed exist, but they are weak,
suggesting the involvement of factors other than membrane
affinity. Electrostatic interactions of the peptides with the
membrane do play an important role in the selectivity of the
peptides. Interestingly, we found that the binding to a 10% anionic
membrane correlates best with hemolytic activity, highlighting the
importance of lipid translocation and small amounts of anionic
lipids in the erythrocyte membrane.
Accurate calculation of membrane binding free energies is not
possible at present, with either explicit or implicit solvation
methods. However, the linear relationship between implicit
membrane transfer energies and experimental binding free energy
allowed us to estimate the membrane concentration at the MIC or
EC50 for a large number of peptides. For many peptides this
concentration was found to be much lower than one would expect
for a ‘carpet’ mechanism. The previous finding that AMPs bind
more strongly to toroidal pores than to the planar membrane is
here confirmed for a larger number of peptides. Interestingly, the
deviation of the MIC from the value expected for the ‘carpet’
model was found to correlate with the transfer energy from planar
membrane to the pores.
The implicit membrane simulations can be used to obtain
additional structural parameters and investigate their correlation
with biological activity. Such parameters include the membrane
surface coverage, the depth of insertion, the tilt angle and the
flexibility. Deeper insertion into the membrane was found to
correlate with hemolytic activity, while flexibility was found to
correlate with antimicrobial activity. A new parameter that
correlates with both activities is the hydrophobic quadrupole, a
measure of imperfect amphipathicity.
Materials and Methods
a) Implicit membrane model
In the EEF1 [81] and IMM1[82] implicit solvation models, the
effective energy (Weff) of a solute is the sum of the intramolecular
energy of the solute (E) and its solvation free energy (DGslv). E is
calculated from a modified version of the CHARMM19 force
field, and DGslv is obtained as the sum of atomic contributions,
each calculated from a Gaussian solvent exclusion model.
The solvation parameters are expressed as a linear combination







where f(z) is a switching function that depends on the position








where T is the thickness of the membrane hydrophobic core. To
describe the effect of anionic lipid on peptide binding, the





qi  W(zi) ð9Þ
where Q(z) is obtained using the Gouy-Chapman theory[37].
The model was extended to pores in neutral [36,83] and anionic
membranes [67]. Two pore shapes are defined: cylindrical and
toroidal. The first is a cylindrical hole inside the membrane filled
with water. No head group is present at the pore wall so that this
type of pore can mimic barrel-stave pores. In the later, the lipid
head groups are bent to line the pore wall and its radius changes
with the z coordinate:
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In anionic pores, the Q(z) was calculated by solving the Poisson-
Boltzman equation. The head group dipoles were mimicked by a
double layer of charges [67]. In this approach an additional
parameter h is introduced as the homogeneity factor, which is the
ratio of the head group density at the center of the pore to that on
the planar membrane. All-atom simulations showed that this
parameter is about 0.6 to 0.7 in pure toroidal pores.
b) MD simulations
MD simulations of AMPs were conducted in planar membranes
with anionic lipid fraction ranging from 0% to 100% in
physiological salt solutions (0.1 M monovalent salt), using the
membrane model presented in the previous section. The structures
of the studied peptides were obtained from the PDB database. For
NMR structures (most common) the lowest energy model for each
peptide was selected and energy minimized using the steepest
descent method for 300 steps. The peptides were placed on the
membrane surface with their long axis parallel to the surface and
rotated with the nonpolar residues facing the membrane. Four
simulations with different random initial velocities were carried
out. Each simulation consisted of 2 ns equilibration followed by 2
ns production. The latter was used for analysis. To calculate the
D,W., we simulated the peptide for 100 ns and used the last 50
ns for analysis. All simulations were carried out using the
CHARMM program [84].
AMPs were also simulated inside cylindrical and toroidal pores
using the standard IMM1 model for neutral pores [36] and the
numerical Poisson-Boltzmann approach for anionic pores [67]. All
pores have a radius of R0 = 13 Å. The toroidal pores have K0 =
15 Å and h = 0.6. Two anionic fractions were studied: 10% and
30%. The peptides were placed adjacent to the pore wall with
their long axis parallel to the pore axis and their nonpolar residues
facing the pore wall. Four simulations with different random initial
velocities were carried out. Each simulation consisted of 3 ns
equilibration followed by 3 ns production. The latter was used for
analysis. The transfer energy to the pores, DDW, was calculated as
the difference between the ,DW. to the pore and the ,DW. to
the planar membrane. To be consistent with the pore simulations,
the ,DW. to planar membrane was calculated using the Poisson-
Boltzmann potential [67] instead of the Gouy-Chapmann theory.
c) Calculation of physical descriptors from MD
simulations
A list of the physical descriptors considered is shown in table 2.
The first five are standard properties that can be obtained from the
sequence.The overall hydrophobicity (H), hydrophobic dipole
moment (mH) and hydrophobic quadrupole moment (Q) of the
peptides were calculated using the method and the consensus scale
introduced by Eisenberg[85]. The original PDB structures were
used to calculate these values. The net charge (ncharge) was
calculated as the sum of the charges of all ionizable groups at pH
7.
Additional descriptors were obtained from the MD simulations.
The binding energy of the peptides to the membrane was
estimated by the average effective energy change (DWw-.m) upon
transferring the peptide from the membrane surface (Wmemb) to
water (Wwater), with conformation fixed. The immersed volume V
was calculated by constructing a grid lattice around the peptide
and counting the number of grids (0.1 Å) that are occupied by
peptide atoms and at the same time are inside the membrane (z,
T/2). The occupied area As was calculated as the volume of
peptide inside a 1 Å slab centered at the membrane surface (z = T/
2) divided by the slab thickness.
The tilt angle of the peptide was calculated as the angle between
the principal axis of the peptide and the membrane normal (z
axis). The insertion depth was calculated as the distance of the
lowest residue of the peptide to the membrane surface. It is a
negative value when the peptide has parts that are buried inside
the membrane. The helix percentage was calculated using DSSP
[86]. The electric dipole of the peptide can be calculated using the
coor dipole command of CHARMM. Because the charged
residues are neutralized in EEF1 and IMM1, we added back the
charge to the charged residues before the calculation. The origin
of the coordinate system was transferred to the peptide mass center
when calculating the electric dipole. The number of hydrogen
bonds nhbond was calculated with cutoff distance 2.5 Å and cutoff
angle 100u. The maximum fluctuation of the peptide (rmsf) is
defined as the maximum value of the root mean square fluctuation
of each residue.
d) Data set
For comparison between experimental free energy and theo-
retical binding energy, 11 peptides were simulated and their DW
was calculated. Experimental binding free energies (DG) were
collected from the literature and summarized in Table S1. All
binding free energy values were converted to the molarity standard
state (DGc
0
, see Section S1).
The study was then extended to a total of 53 helical or partially
helical peptides with known PDB structure selected from the APD
database[87]. Large antimicrobial peptides (.50 residues) and
beta structured peptides were not included in this study to avoid
the complexity of additional structural variables. The activities of
the peptides against E. Coli, P. Aeruginosa (typical Gram-negative
bacteria), and S. Aureus (typical Gram-positive bacterium) were
collected from literature data. These three organisms are most
commonly used for measuring antimicrobial activity. A table
listing the PDB id and activity of studied peptides can be found in
the supplementary material (Table S2), where peptides are
grouped by their origin and family. All the data collected come
from experiments with standard or a variation of broth
microdilution assay[88]. However, different colony formation
units (CFU) are normally used in different studies so we listed the
CFU conditions together with the MIC values in table S2. Data
reported inmg/ml were converted to mM.
For comparing hemolytic activity, the peptide concentrations
required to generate a certain extent of hemolysis are also listed in
Table S2. Although the hemolytic assays were carried out in a
standardized way, the incubation time and cell suspension
concentration vary in different studies. These conditions are also
listed in Table S2. Only the concentration to generate 50%
hemolysis (EC50) was used to determine the relationship between
hemolytic activity and peptide physical descriptors.
e) Relationship between MIC and membrane binding
affinity in the ‘carpet’ model
The MIC is the lowest overall peptide concentration at which
bacterial growth ceases. If this is related to actions of the peptide
on the membrane, the critical factor is the concentration of the
peptide on the membrane. The higher the membrane binding
affinity, the higher this concentration will be. The link between
MIC and peptide concentration on the membrane has been
worked out by Melo et al. [31]:
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where P*:L is the critical molar ratio of membrane bound
peptide to lipid, Kp is the partition coefficient, and vL is the molar
lipid volume. In a typical antibacterial assay, [L] is around
2 nM[54] to 58 nM[31] but the MIC is of the order ofmM and
P*:L is in the range of 1:10 to 1:100; [L] is thus negligible. Because
DGc









This is equivalent to assuming that the unbound peptide
concentration is equal to the MIC. In the ‘carpet’ model, it is
reasonable to assume that the membrane loses its integrity when



















For the ‘carpet’ model, we expect f * to be a constant value. In
implicit simulations, As can be easily obtained andDG
0
c can be
estimated from the transfer energy DW (DG0c ~bDWzc, see
Results).
Hemolysis assays are done at much higher lipid concentra-
tions(20 mM [54] to 89 mM [31]) and [L] in Eq. 11 cannot be












Figure S1 Conformations of various antimicrobial pep-
tides with their hydrophobic quadrupole moments.
(PDF)
Table S1 Compilation of experimental membrane
binding free energies of AMPs, in the molarity standard
state.
(PDF)
Table S2 Theoretical transfer energies and biological
activities of the peptides.
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Table S3 Biological activity of the peptides that do not
have PDB structures.
(PDF)
Table S4 Comparison of the free energy from explicit
simulations with experimental binding free energy and
transfer energy ,DW. from IMM1.
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Table S5 List of peptide mechanism from literature.
(PDF)
Table S6 Transfer energy from planar membrane to
pores.
(PDF)
Table S7 Hydrophobic quadrupole moment of studied
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